MitoRx Therapeutics
Oxford, United Kingdom· Est. 2014
Developing small molecule therapeutics modulating mitochondrial metabolism for weight loss to drive fat loss without any lean mass loss in cardiometabolic disease.
Private Company
Total funding raised: $19.2M
About
Developing small molecule therapeutics modulating mitochondrial metabolism for weight loss to drive fat loss without any lean mass loss in cardiometabolic disease.
Small Molecules
Funding History
2Total raised:$19.2M
Series A$15MFeb 15, 2023
Seed$4.2MMay 15, 2021